Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels-Reference-Cited by-同舟云学术

Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels

Published:2013-08 Issue:8 Volume:11 Page:1493-1502
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Hawes E. M.¹,Deal A. M.²,Funk-Adcock D.³,Gosselin R.⁴,Jeanneret C.⁵,Cook A. M.⁶,Taylor J. M.³,Whinna H. C.⁷,Winkler A. M.⁸,Moll S.⁹

Affiliation:

1. Department of Pharmacy; School of Medicine, Department of Family Medicine; University of North Carolina; Chapel Hill NC USA

2. Lineberger Comprehensive Cancer Center Biostatistics Core; Chapel Hill NC USA

3. Esoterix Inc.; Englewood CO USA

4. Department of Pathology and Laboratory Medicine; University of California, Davis Health; Sacramento CA USA

5. Division of Hematology-Oncology; Department of Medicine; University of North Carolina School of Medicine; Chapel Hill NC USA

6. Loyola University Health System; Maywood IL USA

7. Department of Pathology and Laboratory Medicine; University of North Carolina School of Medicine; Chapel Hill NC USA

8. Department of Pathology & Laboratory Medicine; Emory University School of Medicine; Atlanta GA USA

9. Division of Hematology-Oncology; Department of Medicine; Hemophilia and Thrombosis Center; University of North Carolina School of Medicine; Chapel Hill NC USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12308/fullpdf

Reference21 articles.

1. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate;Douxfils;Thromb Haemost,2012

2. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays;Lindahl;Thromb Haemost,2011

3. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate;Wienen;Thromb Haemost,2007

4. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity;Ryn;Thromb Haemost,2010

5. Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy;Avecilla;Am J Clin Pathol,2012

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline;British Journal of Haematology;2024-09-02

2. Hemostasis Testing in the Emergency Department: A Narrative Review;Seminars in Thrombosis and Hemostasis;2024-06-19

3. Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative Physician;Current Anesthesiology Reports;2024-04-27

4. International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors;International Journal of Laboratory Hematology;2023-06-07

5. Ecarin-Based Methods for Measuring Thrombin Inhibitors;Methods in Molecular Biology;2023